Asit C Mehta Fin (530723)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹151.2 |
| Market Cap | ₹135.29 Cr |
| P/E Ratio | 0 |
| ROCE | 5.41% |
| ROE | -3.92% |
| Dividend Yield | 0% |
| Profit Growth | 23.87% |
| Debt/Equity | — |
| Sales Growth | -11.47% |
| 52-Week Range | ₹92 — ₹164 |
| Sector | Capital Markets |
| Book Value | ₹71.17 |
Strengths
- Piotroski F-Score of 6/9 indicates moderately healthy financials despite recent losses.
- Positive ROCE of 5.41% shows operating capital is earning a return before financing costs.
- Book value of ₹71.17 per share provides a tangible asset cushion.
- Profit growth of 23.87%, though off a weak base, hints at some earnings stabilization effort.
Concerns
- Negative ROE of -3.92% and a latest quarterly net loss of ₹2 Cr mean shareholder returns are unsatisfactory.
- Sales declined 11.47%, showing the business is shrinking in a competitive broking industry.
- Price-to-book of 2.12 with zero earnings offers no margin of safety.
- No dividend yield means investors earn no income while waiting for a recovery.
AI Analysis
When I examine Asit C Mehta Fin, I see a small stockbroking firm with a market price of ₹151.20 and a market capitalisation of just ₹135 crore. A broker is only as good as its ability to generate returns, and this one is not doing that: return on equity is minus 3.92%, and the latest quarter reported sales of ₹14 crore with a net loss of ₹2 crore. Graham taught me to ask whether the earnings power justifies the price. Here, the price-to-earnings ratio is zero because earnings are absent. The company does have a positive return on capital employed of 5.41%, and a Piotroski score of 6 out of 9 suggests reasonable financial health, but that is not enough. Sales are declining by 11.47%, so the underlying business is shrinking. Stockbroking is a brutally competitive industry without durable moats; clients can move their trades to any discount broker. The book value is ₹71.17 per share, yet I am being asked to pay ₹151.20, or 2.12 times book, for a business earning negative returns on equity. That fails my margin-of-safety test. The reported profit growth of 23.87% sounds encouraging, but with a net loss in the latest quarter, it is a small improvement on a weak base, not proof of a durable franchise. There is no dividend, so I receive no income while waiting. In my circle of competence, I prefer businesses with predictable earning power and competitive advantages. This one has neither. The 52-week range of ₹92 to ₹164 also tells me the stock is subject to speculation and market emotions. A prudent investor can wait for a better price or a better business. Asit C Mehta Fin is a possible turnaround if profitability returns, but today the risk-reward is unattractive. I would rather miss the opportunity than overpay for hope.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer